Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | March 17, 2025 05:05pm

Gainers

  • Harrow (NASDAQ:HROW) stock moved upwards by 15.8% to $27.0 during Monday's after-market session. The market value of their outstanding shares is at $961.5 million. The company's, Q4 earnings came out today.
  • Coeptis Therapeutics (NASDAQ:COEP) shares moved upwards by 14.7% to $9.75. The company's market cap stands at $31.6 million.
  • Nanobiotix (NASDAQ:NBTX) stock moved upwards by 14.37% to $3.66. The company's market cap stands at $173.5 million.
  • Enzo Biochem (NYSE:ENZ) stock increased by 8.48% to $0.51. The market value of their outstanding shares is at $26.6 million.
  • Citius Oncology (NASDAQ:CTOR) stock increased by 7.93% to $0.62. The market value of their outstanding shares is at $44.1 million.
  • Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 6.31% to $0.47. The market value of their outstanding shares is at $11.8 million.

Losers

  • Kyverna Therapeutics (NASDAQ:KYTX) shares fell 20.5% to $2.02 during Monday's after-market session. The market value of their outstanding shares is at $87.1 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock decreased by 17.93% to $0.14. The market value of their outstanding shares is at $2.5 million.
  • Hyperfine (NASDAQ:HYPR) shares declined by 12.5% to $1.12. The company's market cap stands at $86.7 million. As per the press release, Q4 earnings came out today.
  • Capstone Holding (NASDAQ:CAPS) shares declined by 9.4% to $2.7. The company's market cap stands at $3.8 million.
  • Entero Therapeutics (NASDAQ:ENTO) shares decreased by 7.77% to $0.49. The market value of their outstanding shares is at $2.3 million.
  • BioAtla (NASDAQ:BCAB) stock declined by 7.7% to $0.33. The company's market cap stands at $19.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BCAB CAPS COEP CTOR ENTO ENZ HROW HYPR KYTX NBTX SNSE VRPX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist